Cargando…
Expected motor function change following decompressive surgery for spinal metastatic disease
BACKGROUND: Motor function in patients with spinal metastatic disease (SMD) directly impacts a patient's ability to receive systemic therapy and overall survival. Spine surgeons may be in the challenging position to advise a patient on expected motor function outcomes and determine a patient...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345847/ https://www.ncbi.nlm.nih.gov/pubmed/37457395 http://dx.doi.org/10.1016/j.xnsj.2023.100240 |
_version_ | 1785073181291184128 |
---|---|
author | Okai, Bernard K. Lipinski, Lindsay J. Ghannam, Moleca M. Fabiano, Andrew J. |
author_facet | Okai, Bernard K. Lipinski, Lindsay J. Ghannam, Moleca M. Fabiano, Andrew J. |
author_sort | Okai, Bernard K. |
collection | PubMed |
description | BACKGROUND: Motor function in patients with spinal metastatic disease (SMD) directly impacts a patient's ability to receive systemic therapy and overall survival. Spine surgeons may be in the challenging position to advise a patient on expected motor function outcomes and determine a patient's suitability as a surgical candidate. We present this study to provide this critical information on anticipated motor function change to spine surgeons. METHODS: Consecutive patients undergoing spinal surgery for SMD at a National Cancer Institute-designated cancer institute were prospectively enrolled. Patient motor function status before and after surgery was assessed using the standard 0 to 5 five-point muscle strength grading scale. The difference in presurgical and postsurgical motor function (proximal and distal) was used to assess motor function changes following surgery. RESULTS: A total of 171 patients were included. The mean age was 62.7±10.46 years and 40.9% (70) were female. Common primary malignancy types were lung (49), kidney (28), breast (25), and prostate (23). The average proximal and distal motor function difference was 0.38 (standard deviation=1.02, p<.0001) and 0.32 (standard deviation=0.91, p<.0001) respectively showing an improvement following surgery. Patients with proximal presurgical motor function of 2, 3, and 4 had an improved motor function in 73%, 77%, and 73% of the patients. Patients with distal presurgical motor function of 2, 3, and 4 had an improved motor function in 80%, 89%, and 70% of the patients. CONCLUSIONS: Most patients undergoing surgery for SMD have a modest improvement in motor function following surgery. The degree of improvement in most instances is less than 1 point on a 0 to 5 motor function scale. This is critical knowledge for a spinal surgeon when evaluating SMD patients with significant preoperative motor function deficits. These results aid spinal surgeons in setting expectations and evaluating the need for rapid spinal decompression. |
format | Online Article Text |
id | pubmed-10345847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-103458472023-07-15 Expected motor function change following decompressive surgery for spinal metastatic disease Okai, Bernard K. Lipinski, Lindsay J. Ghannam, Moleca M. Fabiano, Andrew J. N Am Spine Soc J Clinical Studies BACKGROUND: Motor function in patients with spinal metastatic disease (SMD) directly impacts a patient's ability to receive systemic therapy and overall survival. Spine surgeons may be in the challenging position to advise a patient on expected motor function outcomes and determine a patient's suitability as a surgical candidate. We present this study to provide this critical information on anticipated motor function change to spine surgeons. METHODS: Consecutive patients undergoing spinal surgery for SMD at a National Cancer Institute-designated cancer institute were prospectively enrolled. Patient motor function status before and after surgery was assessed using the standard 0 to 5 five-point muscle strength grading scale. The difference in presurgical and postsurgical motor function (proximal and distal) was used to assess motor function changes following surgery. RESULTS: A total of 171 patients were included. The mean age was 62.7±10.46 years and 40.9% (70) were female. Common primary malignancy types were lung (49), kidney (28), breast (25), and prostate (23). The average proximal and distal motor function difference was 0.38 (standard deviation=1.02, p<.0001) and 0.32 (standard deviation=0.91, p<.0001) respectively showing an improvement following surgery. Patients with proximal presurgical motor function of 2, 3, and 4 had an improved motor function in 73%, 77%, and 73% of the patients. Patients with distal presurgical motor function of 2, 3, and 4 had an improved motor function in 80%, 89%, and 70% of the patients. CONCLUSIONS: Most patients undergoing surgery for SMD have a modest improvement in motor function following surgery. The degree of improvement in most instances is less than 1 point on a 0 to 5 motor function scale. This is critical knowledge for a spinal surgeon when evaluating SMD patients with significant preoperative motor function deficits. These results aid spinal surgeons in setting expectations and evaluating the need for rapid spinal decompression. Elsevier 2023-07-02 /pmc/articles/PMC10345847/ /pubmed/37457395 http://dx.doi.org/10.1016/j.xnsj.2023.100240 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Clinical Studies Okai, Bernard K. Lipinski, Lindsay J. Ghannam, Moleca M. Fabiano, Andrew J. Expected motor function change following decompressive surgery for spinal metastatic disease |
title | Expected motor function change following decompressive surgery for spinal metastatic disease |
title_full | Expected motor function change following decompressive surgery for spinal metastatic disease |
title_fullStr | Expected motor function change following decompressive surgery for spinal metastatic disease |
title_full_unstemmed | Expected motor function change following decompressive surgery for spinal metastatic disease |
title_short | Expected motor function change following decompressive surgery for spinal metastatic disease |
title_sort | expected motor function change following decompressive surgery for spinal metastatic disease |
topic | Clinical Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345847/ https://www.ncbi.nlm.nih.gov/pubmed/37457395 http://dx.doi.org/10.1016/j.xnsj.2023.100240 |
work_keys_str_mv | AT okaibernardk expectedmotorfunctionchangefollowingdecompressivesurgeryforspinalmetastaticdisease AT lipinskilindsayj expectedmotorfunctionchangefollowingdecompressivesurgeryforspinalmetastaticdisease AT ghannammolecam expectedmotorfunctionchangefollowingdecompressivesurgeryforspinalmetastaticdisease AT fabianoandrewj expectedmotorfunctionchangefollowingdecompressivesurgeryforspinalmetastaticdisease |